Cargando…
The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance
SARS-CoV-2 Lambda, a variant of interest, has spread in some South American countries; however, its virological features and evolutionary traits remain unclear. In this study, we use pseudoviruses and reveal that the spike protein of the Lambda variant is more infectious than that of other variants...
Autores principales: | Kimura, Izumi, Kosugi, Yusuke, Wu, Jiaqi, Zahradnik, Jiri, Yamasoba, Daichi, Butlertanaka, Erika P., Tanaka, Yuri L., Uriu, Keiya, Liu, Yafei, Morizako, Nanami, Shirakawa, Kotaro, Kazuma, Yasuhiro, Nomura, Ryosuke, Horisawa, Yoshihito, Tokunaga, Kenzo, Ueno, Takamasa, Takaori-Kondo, Akifumi, Schreiber, Gideon, Arase, Hisashi, Motozono, Chihiro, Saito, Akatsuki, Nakagawa, So, Sato, Kei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s).
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683271/ https://www.ncbi.nlm.nih.gov/pubmed/34968415 http://dx.doi.org/10.1016/j.celrep.2021.110218 |
Ejemplares similares
-
The SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variant
por: Kimura, Izumi, et al.
Publicado: (2022) -
Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant
por: Yamasoba, Daichi, et al.
Publicado: (2023) -
Generation of a bovine cell line for gene engineering using an HIV-1-based lentiviral vector
por: Morizako, Nanami, et al.
Publicado: (2022) -
SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion
por: Ferreira, Isabella A T M, et al.
Publicado: (2021) -
Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies
por: Yamasoba, Daichi, et al.
Publicado: (2022)